lysozyme

Biologicalexperimental

Lysozyme is an antimicrobial enzyme produced by animals that forms part of the innate immune system. It is a glycoside hydrolase that catalyzes the following process:Hydrolysis of (1→4)-β-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins — Wikipedia

Clinical trial activity

6 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
2

Earliest trial started Aug 1, 2012 (NCT01645800)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • lysozyme
  • lysozyme
  • lysozyme chloride
  • lysozyme hydrochloride

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05519254Phase 3Jan 31, 2023National Institutes of Health (NIH), University of Washington
NCT05342272Phase 3Sep 22, 2017Spedali Civili di Brescia, University of Brescia
NCT03282045Phase 3Oct 31, 2016Istanbul University, Kocaeli University, MonitorCRO
NCT02925026N/AOct 1, 2016University of Malawi, Washington University in St. Louis
NCT01715493Phase 4Oct 1, 2012Eisai
NCT01645800Phase 4Aug 1, 2012Eisai
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
EisaiFor profit2212012
Istanbul UniversityAcademic/Hospital1012016
Kocaeli UniversityAcademic/Hospital1112016
MonitorCROFor profit1012016
National Institutes of Health (NIH)Government1012023
Spedali Civili di BresciaAcademic/Hospital1112017
University of BresciaAcademic/Hospital1012017
University of MalawiAcademic/Hospital1012016
University of WashingtonAcademic/Hospital1112023
Washington University in St. LouisAcademic/Hospital1112016
10 organizations
Page 1 / 1